NCT05943262

Brief Summary

The research aims to develop a novel pathological technology, including rapid whole-mount tissue H\&E \& IHC staining protocol and high-resolution nonlinear optical microscopy imaging system, to intraoperatively assess brain tumor grade, types and other biological parameters.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
May 2023Dec 2026

Study Start

First participant enrolled

May 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

August 21, 2024

Status Verified

May 1, 2024

Enrollment Period

3.7 years

First QC Date

June 18, 2023

Last Update Submit

August 19, 2024

Conditions

Keywords

brain tumorbrain cancer

Outcome Measures

Primary Outcomes (2)

  • Develop a standard whole-mount tissue processing protocol

    In this research, the investigators will try to create a standard staining protocol to perform rapid whole-mount H\&E and IHC staining on surgical brain tumor specimens, so that the cell morphology (ex: cell shape, cell size, etc) and cell types (ex: astrocytes, oligodendrocytes, T-cells, B-cells, etc) in the images of those tissues can be observed via nonlinear optical microscopy, and the treatment strategy can be set based on subtyping and grading the brain tumors by the pathologists.

    3 years

  • Obtain images from H&E and IHC stained brain tumor tissues by nonlinear optical microscopy

    Images of brain tumor specimens will be taken by nonlinear optical microscopy and a image database of brain tumors can be created (ex: cell shape, cell size and cell density of different cells in human brain tissues).

    3 years

Secondary Outcomes (1)

  • Distinguish between normal tissue and brain tumor and determine the extent and grade of the brain tumors

    3 years

Study Arms (1)

mesoscale nonlinear optical microscope + whole-mount H&E & IHC staining protocol

Device: mesoscale nonlinear optical microscope

Interventions

The mesoscale nonlinear optical microscope based on the principles of nonlinear optics and computed-algorithms can acquire large-area image within few minutes.

mesoscale nonlinear optical microscope + whole-mount H&E & IHC staining protocol

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients older than the age of 20 with diagnosis of brain tumor (both newly-diagnosed or recurrent) who are suitable and willing to receive resection surgery will be recruited.

You may qualify if:

  • \. Patients older than the age of 20 with diagnosis of brain tumor (both newly-diagnosed or recurrent) who are suitable and willing to receive resection surgery.

You may not qualify if:

  • Patients who cannot give consent to participate in the study.
  • The tumor samples failed to give a conclusive pathological diagnosis by standard pathological workflow.
  • Patients who only receives biopsy surgery rather than resection surgery.
  • Significant post-irradiation effect or radiation necrosis reported in the pathological examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Brain Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2023

First Posted

July 13, 2023

Study Start

May 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

August 21, 2024

Record last verified: 2024-05

Locations